The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet? Journal Article

  

Authors:	Geller, S.; Myskowski, P. L.; Kim, Y. H.; Moskowitz, A.; Horwitz, S.
Article Title:	The optimal regimen of brentuximab vedotin for CD30(+) cutaneous lymphoma: Are we there yet?
Journal Title:	British Journal of Dermatology
Volume:	178
Issue:	2
ISSN:	0007-0963
Publisher:	Blackwell Publishing
Date Published:	2018-02-01
Start Page:	571
Language:	English
DOI:	10.1111/bjd.16052
PROVIDER:	scopus
PUBMED:	29023638
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85038077725&doi=10.1111%2fbjd.16052&partnerID=40&md5=5172cffa713ba8cbc3dfd9a861340821
Notes:	Letter -- Export Date: 1 March 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/121460